IMS Health — Merger or Acquisition (May 2016)
10 slides from IMS Health's merger presentation, May 11, 2016
Slide 1: Quintiles and IMS Health to Merge: Announcement Overview
Quintiles and IMS Health to Merge Announcement overview May 2016
Slide 2: Cautionary Notes on Forward Looking Statements
Cautionary Notes on Forward Looking Statements This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this cont
Slide 3: Important Information About the Transaction and Where to Find It
Important Information About the Transaction and Where to Find It In connection with the proposed transaction, IMS Health and Quintiles will be filing documents with the Securities and Exchange Commission (“SEC”), including the filing by Quintiles of a registration statement on Form S-4, and Quintile
Slide 4: Overview: Announced merger with IMS Health
Overview Announced merger with IMS Health Proposed merger announced May 3, 2016 Merger of equals Primary focus remains on operational delivery and service quality Merger will have limited impact on operations Complementary capabilities Transform clinical development and commercialization through use
Slide 5: Two Best-in-Class Businesses
Two Best-in-Class Businesses Complementary offerings 2015 Revenue Differentiated Resources Leading Capabilities Revenue: $4.3B >1,100 medical doctors, ~1,050 PhDs, ~850 biostatisticians & statistical programmers Quintiles Infosario® platform: >298,000 clinical investigators, clinical research data a
Slide 6: Realize Greater R&D Efficiency, Demonstrate Value, Maximize Commercial ROI
Transformational Partner To Life Sciences Realize Greater R&D Efficiency Demonstrate Value & Measure Outcomes Maximize Commercial ROI Equipping therapeutic, scientific, and domain experts from the world’s largest CRO with industry-leading data and information Designing better trials and driving spee
Slide 7: Realize greater R&D efficiency
Transformational Partner To Life Sciences Realize greater R&D efficiency 530M+ anonymous patient records 14M+ healthcare professional reference database; 70+ countries 500k clinical investigators Information assets in 90 markets 430+ direct-to patient studies Data collection experience from ~5,700 s
Slide 8: Demonstrate value and measure outcomes
Transformational Partner To Life Sciences Demonstrate value and measure outcomes 530M+ anonymous patient records 415+ patient registries and post-approval programs since 2011 E360 ® SaaS Technology Industry shaping leader in patient registries 1 2,300+ technical & scientific resources across 100 geo
Slide 9: Maximize commercial ROI
Transformational Partner To Life Sciences Maximize commercial ROI Portfolio of business intelligence tools for commercial operations 6,700+ global contract sales representatives IMS SaaS Technology for MCM, MDM, Compliance 2015 Leader in Life Sciences IT Outsourcing, BPO, CRM 1 137K CRM seats >80% S
Slide 10: World-class talent
World-class talent ~50,000 strong employee base 15,000+ employees serving clients across 100+ countries 1,200+ healthcare informatics experts worldwide 7,000+ employees in commercial services 3,000+ offshore delivery employees Quintiles 36,000+ employees serving clients across 100+ countries 1,100+
IMS Health Holdings — Merger or Acquisition (May 2016) on 6ix